![]() |
市場調查報告書
商品編碼
1305164
全球體液採集和診斷市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測Global Body Fluid Collection And Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
據預測,全球體液採集與診斷市場需求將從2022年的334.1億美元增至2030年的696.6億美元,2023-2030年的複合年成長率為9.62%。
體液採集和診斷是指採集、分析和檢測體內各種液體,如血液、尿液、唾液和腦脊液。進行這些檢測是為了診斷和監測各種病症,包括傳染病、癌症、代謝紊亂和荷爾蒙失調。體液採集和診斷涉及多個步驟,包括採集樣本、準備分析樣本和使用各種診斷技術分析樣本。體液採集可通過各種方法進行,包括靜脈穿刺、尿液採集和唾液採集。樣本採集完成後,將在實驗室進行處理並使用一系列診斷方法進行分析,如顯微鏡檢查、培養和分子診斷。這些檢查可提供有關體內是否存在特定物質的資訊,如蛋白質、激素和酶,以及是否存在異常細胞或微生物。體液採集和診斷檢測的結果可用於診斷病情、監測疾病進展和評估治療效果。這些檢測是現代醫療實踐的重要組成部分,在疾病預防和管理方面發揮著重要作用。
需要定期進行體液檢測的慢性疾病發病率不斷上升,推動了對體液採集和診斷技術的需求。液體活體組織切片和新一代測序等先進診斷技術的發展提高了體液採集和診斷的準確性和效率。患者和醫療服務提供者對微創手術的採用推動了對微創體液採集方法的需求。人們對早期疾病檢測重要性的認知不斷提高,這推動了對體液採集和診斷技術的需求,因為這些檢測有助於在疾病更易治療的早期階段發現疾病。許多國家政府正在實施促進早期疾病檢測和改善醫療設施的計劃,這推動了體液採集與診斷市場的成長。遠程醫療和虛擬會診已變得越來越普遍,使個人更容易在家中獲得體液採集和診斷服務。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰了解行業結構,評估全球競爭吸引力。此外,這些工具還對全球體液採集與診斷市場的各個細分市場進行了全面評估。體液採集與診斷行業的成長和趨勢為本研究提供了整體方法。
體液採集與診斷市場報告的這一部分提供了國家和地區層面細分市場的詳細數據,從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太、拉丁美洲以及中東和非洲地區體液採集與診斷市場的當前和未來需求。此外,報告還重點關注了所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。體液採集和診斷市場的主要參與者包括賽默飛世爾科技公司、Bio-Rad實驗室、Illumina公司、Guardant Health、QIAGEN、強生公司、美國實驗室公司控股、Biocept公司、F. Hoffmann-La Roche Ltd.、MDxHealth SA。本節包括競爭格局的整體視圖,其中包括各種戰略發展,如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。
*注:在公司概況中,財務細節和近期發展取決於可用性,如果是私營公司,則可能不包括在內。
The global demand for Body Fluid Collection And Diagnostics Market is presumed to reach the market size of nearly USD 69.66 BN by 2030 from USD 33.41 BN in 2022 with a CAGR of 9.62% under the study period 2023 - 2030.
Body fluid collection and diagnostics refer to the collection, analysis, and testing of various fluids within the body, such as blood, urine, saliva, and cerebrospinal fluid. These tests are performed to diagnose and monitor various medical conditions, including infectious diseases, cancer, metabolic disorders, and hormonal imbalances. Body fluid collection and diagnostics involve several steps, including the collection of the sample, preparation of the sample for analysis, and analysis of the sample using various diagnostic techniques. The collection of body fluids can be done through various methods, including venipuncture, urine collection, and saliva collection. Once the sample has been collected, it is processed and analyzed in a laboratory using a range of diagnostic methods, such as microscopy, culture, and molecular diagnostics. These tests can provide information related to the presence of specific substances in the body, such as proteins, hormones, and enzymes, as well as the presence of abnormal cells or microorganisms. The results of body fluid collection and diagnostics tests can be used to diagnose medical conditions, monitor the progression of any disease, and evaluate the effectiveness of treatments. These tests are an essential part of modern medical practice and play a vital role in disease prevention and management.
The increasing incidence of chronic diseases which require regular body fluid testing, is driving the demand for body fluid collection and diagnostics. The development of advanced diagnostic techniques and technologies, such as liquid biopsy and next-generation sequencing, has improved the accuracy and efficiency of body fluid collection and diagnostics. The adoption of minimally invasive procedures among patients and healthcare providers is driving the demand for less invasive body fluid collection methods. The awareness about the importance of early disease detection is scaling up, which is driving the demand for body fluid collection and diagnostics, as these tests can help detect diseases at an early stage when they are more treatable. Many governments are implementing initiatives to promote early disease detection and improve healthcare facilities, which is driving the growth of the body fluid collection and diagnostics market. Telemedicine and virtual consultations have become more prevalent, making it easier for individuals to access body fluid collection and diagnostic services from the comfort of their homes.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of body fluid collection and diagnostics. The growth and trends of body fluid collection and diagnostics industry provide a holistic approach to this study.
This section of the body fluid collection and diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Body Fluid Collection And Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the body fluid collection and diagnostics market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Illumina Inc, Guardant Health, QIAGEN, Johnson & Johnson, Laboratory Corporation of America Holdings, Biocept Inc, F. Hoffmann-La Roche Ltd., MDxHealth SA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies